Literature DB >> 25502548

MTA1 downregulation inhibits malignant potential in a small cell lung cancer cell line.

Hongsheng Xue1, Haijuan Wang1, Jian Liu1, Huan Liu1, Chunxiao Li1, Li Han2, Chen Lin1, Qimin Zhan1, Zhilong Zhao2, Haili Qian1.   

Abstract

As a component of the nuclear remodeling and deacetylation complex (NuRD complex), metastasis-associated gene 1 (MTA1) has been reported to play a key role in cancer malignancy. However, whether MTA1 functions in small cell lung cancer (SCLC) malignant behavior and whether it is feasible to be used as a therapeutic target have not been evaluated. The present study aimed to investigate the effects of MTA1 downregulation on SCLC malignancy. First we demonstrated the overexpression of MTA1 in SCLC specimens. After knocking down the MTA1 level by specific siRNA sequence, the biological consequences on proliferation, migration, invasion and apoptosis were evaluated. The results showed that MTA1 silencing had potent suppressive effects on SCLC proliferation, migration and invasion. Apoptosis but not cell cycle arrest was induced in the MTA1-silenced SCLC cells. In summary, MTA1 plays a critical role in regulating the malignant behaviors of SCLC. Depleting MTA1 level may be an effective strategy by which to suppress SCLC growth and metastasis in future biotherapeutic attempts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25502548     DOI: 10.3892/or.2014.3671

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  miR-126/VCAM-1 regulation by naringin suppresses cell growth of human non-small cell lung cancer.

Authors:  Mingjiu Chen; Weilin Peng; Shifeng Hu; Jie Deng
Journal:  Oncol Lett       Date:  2018-07-24       Impact factor: 2.967

2.  A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.

Authors:  Lina Li; Jian Liu; Hongsheng Xue; Chunxiao Li; Qun Liu; Yantong Zhou; Ting Wang; Haijuan Wang; Haili Qian; Tao Wen
Journal:  Oncogene       Date:  2019-12-06       Impact factor: 9.867

3.  Prognostic value of MTA1, SOX4 and EZH2 expression in esophageal squamous cell carcinoma.

Authors:  Wenying Liu; Yu Xia; Mengyan Li; Gulinaer Abulajiang; Hui Wang; Liping Su; Chao Li; Yan Shi; Wenjing Zhang; Shanshan Xu; Yuqing Ma
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

4.  MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.

Authors:  Ning Zhou; Haijuan Wang; Hongxu Liu; Hongsheng Xue; Feng Lin; Xiting Meng; Ailing Liang; Zhilong Zhao; YongJun Liu; Haili Qian
Journal:  J Exp Clin Cancer Res       Date:  2015-12-23

5.  Expression of MTA1 in endometriosis and its relationship to the recurrence.

Authors:  Jing Zhang; Haiyan Wang; Qiu Meng; Jin Chen; Jie Wang; Shouguo Huang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

6.  MTA1 promotes proliferation and invasion in human gastric cancer cells.

Authors:  Yuan Yao; Shuting Feng; Mingming Xiao; Yan Li; Li Yang; Jiao Gong
Journal:  Onco Targets Ther       Date:  2015-07-20       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.